Vivani Medical logo
Vivani Medical
VANI | NASDAQ
Chart Builder DCF Calculator
$1.02
+$0.01 (+0.99%)
At close: Nov 16, 2026, 4:00 PM ET
$1.00
-$0.02 (-2.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Vivani Medical Company Profile

Company profile explained

Company Profile

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.

Key Executives

Name Position
Adam Mendelsohn Co-Founder, Chief Executive Officer & Director
Anthony Edward Baldor Chief Financial Officer
Donald Dwyer Chief Business Officer & Corporate Secretary
Lisa E. Porter Chief Medical Officer
Truc Le Chief Operations Officer

Latest SEC Filings

Date Type Title
Oct 30, 2026 8-K Current Report
Oct 29, 2026 8-K Current Report
Oct 19, 2026 4 Filing
Sep 25, 2026 424B5 Filing
Sep 16, 2026 8-K Current Report
Aug 17, 2026 8-K Current Report
Aug 13, 2026 8-K Current Report
Aug 13, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
Jul 30, 2026 4 Filing
View All SEC Filings ➞
Vivani Medical
Vivani Medical logo
Country United States
IPO Date Nov 19, 2014
Industry Biotechnology
Sector Healthcare
Employees 42
CEO Adam Mendelsohn

Contact Details

1350 S. Loop Road Alameda, California 94502 United States

Stock Details

Ticker Symbol VANI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001266806
CUSIP Number 92854B109
ISIN Number US92854B1098
SIC Code 3845

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.